MedTrace Logo

The Effect of Hydrodissection for Carpal Tunnel Syndrome

NCT02991001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2018-08-02

No results posted yet for this study

Summary

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is characterized by remission and recurrence. The hydrodissection could decrease the entrapment of nerve to restore blood supply. Despite the hydrodissection was pervasively used in clinical practice, current researches contain small participant without control group or randomized leading to foreseeable selection bias. The investigators design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided hydrodissection in patients with CTS.

Conditions

  • Carpal Tunnel Syndrome

Interventions

PROCEDURE

Ultrasound-guided hydrodissection

Ultrasound-guided hydrodissection with 5cc normal saline between carpal tunnel and median nerve.

PROCEDURE

Placebo ultrasound-guided injection

Ultrasound-guided injection with 5cc normal saline at subcutaneous layer beyond carpal tunnel

DEVICE

Ultrasound

DRUG

Normal Saline

Sponsors & Collaborators

  • Tri-Service General Hospital

    lead OTHER

Principal Investigators

  • Yung-Tsan Wu, MD · Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-04-15
Completion
2018-04-15

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02991001 on ClinicalTrials.gov